“In the past decade, U.S. investments in science, technology and innovation have led to critical breakthroughs in prevention, diagnosis and treatment of deadly global diseases,” Ellie Dehoney and Morgan McCloskey of Research!America, write in a post in USAID’s “IMPACTblog,” noting the development of vaccines, diagnostic technologies and new drugs for neglected diseases, as well as efforts “to expand access to treatment for millions through programs like PEPFAR and USAID’s Neglected Tropical Disease (NTD) program.” However, they continue, “there is still much work to be done. Global diseases like HIV/AIDS, malaria and tuberculosis take eight lives per minute.” They state, “Developing new tools to combat these diseases is critical not only for saving lives, but also for allowing individuals to achieve their earning potential and enabling impoverished nations to develop sustainable economies” (5/6).